Serum Institute of India receives purchase order from Centre
By Lokmat English Desk | Published: January 11, 2021 05:34 PM2021-01-11T17:34:23+5:302021-01-11T17:35:17+5:30
The Serum Institute on India on Monday said it has received the purchase order from the Centre for the ...
Serum Institute of India receives purchase order from Centre
The Serum Institute on India on Monday said it has received the purchase order from the Centre for the Oxford-AstraZeneca COVID-19 vaccine.
"We have received the (purchase) order from the Government of India on Monday afternoon," said a senior SII official.
The government has already announced that the process of administering the vaccine will start on on January 16. The vaccine would be available at the price of Rs 200 per dose, said the SII official.
The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.
Open in appCORRECTION: The vaccine would be available at the price of Rs 200 per dose*: Serum Institute of India (SII) officials#COVID19https://t.co/9NdDRYXrGjpic.twitter.com/E2j0Ogv045
— ANI (@ANI) January 11, 2021
